BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Daxor Corporation Announces That Durham VA Medical Center Acquires BVA-100 Blood Volume Analyzer to Assess Obesity-Related Hemodilution of Serum Cancer Markers

  October 19, 2009

   · 

  2 min read
• Drug Development

  Optimer Pharmaceuticals, Inc. Announces Presentations of Additional Data From the Fidaxomicin North American Phase 3 Trial at Upcoming IDSA Annual Meeting

  October 19, 2009

   · 

  1 min read
• Drug Development

  New Data Presented at ACR Meeting Demonstrates Colcrys(TM) (Colchicine, USP) Significantly Reduces Pain of Acute Gout Flare Within 24 Hours With Side Effects Comparable to Placebo Studies Confirm Clinical Benefit, Reveal New Information on Safety and Phar

  October 19, 2009

   · 

  7 min read
• Drug Development

  Bristol-Myers Squibb Company: ORENCIA(R) (abatacept) Demonstrated Sustained Clinical Response in a Study of Adult Patients with Moderate to Severe Early Rheumatoid Arthritis (Less Than Two Years Duration)

  October 19, 2009

   · 

  1 min read
• Business

  New Reporting Date, Vitrolife’s Interim Report and Invitation to Conference Call on the Interim Report

  October 19, 2009

   · 

  1 min read
• Biotech Bay

  Hansen Medical Announces Need to Restate Prior Financial Results

  October 19, 2009

   · 

  4 min read
• Biotech Beach

  BIO-Europe 2009 Announces Program Highlights

  October 19, 2009

   · 

  1 min read
• Business

  SYGNIS Pharma AG Secures Up To € 10 Million Through A 3 Year Standby Equity Distribution Agreement (SEDA) With Yorkville

  October 19, 2009

   · 

  3 min read
• Biotech Beach

  Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming

  October 19, 2009

   · 

  4 min read
• Deals

  QLT Inc. Gets Rights to Sell Visudyne in US from Novartis Pharma AG (JOBS)

  October 19, 2009

   · 

  1 min read